Denmark NewsNews on Denmark continually updated from thousands of sources around the net.France, Italy opposed in fuel tax plan- June 20, 2008 Germany and various Scandinavian countries opposed French and Italian suggestions to use value-added taxes to lower fuel prices, officials said.http://www.topix.net/world/denmark/2008/06/france-italy-opposed-in-fuel-tax-plan?fromrss=1 Health Economic Analysis Reports That Revlimid is a Cost Effective Treatment for Multiple Myeloma- June 19, 2008 The results showed that not only was the use of REVLIMID and dexamethasone associated with a substantial improvement in survival, but also was cost-effective with the incremental cost-effectiveness threshold ...http://www.topix.net/world/denmark/2008/06/health-economic-analysis-reports-that-revlimid-... Seals may be able to use stars for navigation- June 18, 2008 London, June 17: A team of biologists from the University of Southern Denmark has suggested that seals may be able to use the stars for navigation.http://www.topix.net/world/denmark/2008/06/seals-may-be-able-to-use-stars-for-navigation?f... Cocaine Stash Glued Under Woman's Big Wig- June 18, 2008 A British woman's bulging wig did not fool customs agents in Norway who discovered a kilogram of cocaine glued to her head.http://www.topix.net/world/denmark/2008/06/cocaine-stash-glued-under-womans-big-wig?fromrs... New Analysis of Phase III Studies Shows that REVLIMID(R) Plus...- June 18, 2008 Celgene International Sarl announced that according to data from a pooled study presented at the 13th European Hematology Association congress in Copenhagen, Denmark, multiple myeloma patients taking REVLIMID ...http://www.topix.net/world/denmark/2008/06/new-analysis-of-phase-iii-studies-shows-that-re... Preliminary Results from International Study Report That REVLIMID(R)...- June 16, 2008 COPENHAGEN, Denmark - Celgene International S rl today announced that preliminary data from an international study of single agent REVLIMID in relapsedrefractory aggressive non-Hodgkin ' s lymphoma were ...http://www.topix.net/world/denmark/2008/06/preliminary-results-from-international-study-re... Antisoma announces AS1413 (Xanafide) presentation at EHA- June 16, 2008 London, UK, and Copenhagen, Denmark: 16 June 2008 - Cancer drug developer Antisoma plc announces that a review of data supporting the development of AS1413 in secondary acute myeloid leukaemia was presented ...http://www.topix.net/world/denmark/2008/06/antisoma-announces-as1413-xanafide-presentation... Positive Clinical Data for PBI-1402 Presented at the Annual Congress...- June 15, 2008 ProMetic Life Sciences Inc. today presented results on its orally-active PBI-1402 compound in clinical trial in patients with chemotherapy-induced anemia at the 13th Congress of the European Hematology ...http://www.topix.net/world/denmark/2008/06/positive-clinical-data-for-pbi-1402-presented-a... VIDAZA(R) Continues to Show Significant Overall Survival Benefit when ...- June 14, 2008 Celgene International Sarl announced that data showed VIDAZA provides a significant overall survival benefit for patients with higher-risk myelodysplastic syndromes regardless of whether patients were treated ...http://www.topix.net/world/denmark/2008/06/vidaza-r-continues-to-show-significant-overall-... Data Presented at the 13th Congress of the European Hematology...- June 13, 2008 Jun 13, 2008 - The Myelodysplastic Syndromes Foundation announced today that data presented at the 13th annual Congress of the European Hematology Association in Copenhagen, Denmark continues to demonstrate ...http://www.topix.net/world/denmark/2008/06/data-presented-at-the-13th-congress-of-the-euro... |